Molidustat for Japanese Patients With Renal Anemia Receiving Dialysis

INTRODUCTION: Molidustat, a hypoxia-inducible factor prolyl hydroxylase inhibitor for renal anemia treatment, was evaluated in 5 phase 3 studies (MIYABI program). We report the results of the MIYABI hemodialysis-maintenance study. METHODS: This 52-week, randomized, double-blinded, double-dummy study...

Descripción completa

Detalles Bibliográficos
Autores principales: Akizawa, Tadao, Yamada, Takashi, Nobori, Kiyoshi, Matsuda, Yoshimi, Hayashi, Yasuhiro, Hayasaki, Takanori, Yamamoto, Hiroyasu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484124/
https://www.ncbi.nlm.nih.gov/pubmed/34622100
http://dx.doi.org/10.1016/j.ekir.2021.07.015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8484124/
https://www.ncbi.nlm.nih.gov/pubmed/34622100
http://dx.doi.org/10.1016/j.ekir.2021.07.015

Ejemplares similares